Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on April 21, 2008

Circulation. 2008
Published online before print April 21, 2008, doi: 10.1161/CIRCULATIONAHA.107.189473
A more recent version of this article appeared on May 6, 2008
 Free Article
This Article
Free upon publication Free Article
Right arrow Full Text (PDF)
Right arrow Correction
Right arrow Correction (v120,pe55)
Right arrow All Versions of this Article:
117/18/2407    most recent
CIRCULATIONAHA.107.189473v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vetter, V. L.
Right arrow Articles by Webb, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vetter, V. L.
Right arrow Articles by Webb, C. L.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Heart Diseases
Related Collections
Right arrow Other Ethics and Policy
Right arrow Cardiovascular Pharmacology
Right arrow Cerebrovascular disease/stroke
Right arrow Electrocardiology
Right arrow Arrhythmias, clinical electrophysiology, drugs

Submitted on ,
Accepted on ,

Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs. A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing

Victoria L. Vetter MD, FAHA, Chair, Josephine Elia MD, Christopher Erickson MD, Stuart Berger MD, FAHA, Nathan Blum MD, Karen Uzark RN, PhD, FAHA, and Catherine L. Webb MD, FAHA


Key words: AHA Scientific Statements • attention deficit disorder with hyperactivity • cardiovascular monitoring • congenital heart disease • stimulant drugs • death, sudden • heart arrest • pediatrics




This article has been cited by other articles:


Home page
 cfpHome page
M. McLeod, T. Laubscher, L. Regier, and B. Jensen
Taking the stress out of individualizing ADHD drug therapy
Can Fam Physician, September 1, 2009; 55(9): 895 - 898.
[Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
M. S. Gould, B. T. Walsh, J. L. Munfakh, M. Kleinman, N. Duan, M. Olfson, L. Greenhill, and T. Cooper
Sudden Death and Use of Stimulant Medications in Youths
Am J Psychiatry, September 1, 2009; 166(9): 992 - 1001.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
B. Vitiello and K. Towbin
Stimulant Treatment of ADHD and Risk of Sudden Death in Children
Am J Psychiatry, September 1, 2009; 166(9): 955 - 957.
[Full Text] [PDF]

Home page
 PediatricsHome page
W. B. Brinkman, S. N. Sherman, A. R. Zmitrovich, M. O. Visscher, L. E. Crosby, K. J. Phelan, and E. F. Donovan
Parental Angst Making and Revisiting Decisions About Treatment of Attention-Deficit/Hyperactivity Disorder
Pediatrics, August 1, 2009; 124(2): 580 - 589.
[Abstract] [Full Text] [PDF]

Home page
 Adv. Psychiatr. Treat.Home page
G. Bates
Drug treatments for attention-deficit hyperactivity disorder in young people
Adv. Psychiatr. Treat., May 1, 2009; 15(3): 162 - 171.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
B. J Cowles
Lisdexamfetamine for Treatment of Attention-Deficit/Hyperactivity Disorder
Ann. Pharmacother., April 1, 2009; 43(4): 669 - 676.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. D. Mosholder, K. Gelperin, T. A. Hammad, K. Phelan, and R. Johann-Liang
Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children
Pediatrics, February 1, 2009; 123(2): 611 - 616.
[Abstract] [Full Text] [PDF]

Home page
 Circ Cardiovasc Qual OutcomesHome page
L. K. Leslie, M. E. Alexander, T. A. Trikalinos, J. T. Cohen, S. K. Parsons, and J. W. Newburger
Reexamining the Emperor's New Clothes: Ambiguities in Current Cardiac Screening Recommendations for Youth With Attention Deficit Hyperactivity Disorder
Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 134 - 137.
[Full Text] [PDF]

Home page
 PediatricsHome page
J. Conway, K. K. Wong, C. O'Connell, and A. E. Warren
Cardiovascular Risk Screening Before Starting Stimulant Medications and Prescribing Practices of Canadian Physicians: Impact of the Health Canada Advisory
Pediatrics, October 1, 2008; 122(4): e828 - e834.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. M. Perrin, R. A. Friedman, T. K. Knilans, the Black Box Working Group, and the Section on Cardiology and Cardiac Surgery
Cardiovascular Monitoring and Stimulant Drugs for Attention-Deficit/Hyperactivity Disorder
Pediatrics, August 1, 2008; 122(2): 451 - 453.
[Full Text] [PDF]

Home page
 AAP NewsHome page
L. O'Keefe
ECGs for all ADHD patients? * AAP-AHA release joint 'clarification' on AHA recommendation
AAP News, June 1, 2008; 29(6): 1 - 1.
[Full Text] [PDF]

Home page
 AAP Grand RoundsHome page
D. Bernhardt
ECG Screening of Young Athletes for Cardiac Disease
AAP Grand Rounds, June 1, 2008; 19(6): 63 - 64.
[Full Text] [PDF]

Home page
 Journal Watch CardiologyHome page
AHA Statement on Stimulants and Cardiovascular Screening
Journal Watch Cardiology, May 28, 2008; 2008(528): 1 - 1.
[Full Text]


Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.